| Home > Publications database > Reply to: 'Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology,' 'Key Methodological Considerations in the Interpretation of the CONKO-007 Trial,' and 'Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer'. |
| Journal Article (Letter) | DKFZ-2026-00820 |
; ; ; ;
2026
American Society of Clinical Oncology
Alexandria, Va.
|
The record appears in these collections: |